Loading...
Fedora preliminary analysis of a Phase II study evaluating the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis
McMullin, M. F. Ghebretinsea, F. Boucher, R. Francis, S. Horne, G. Hussein, H. Knapper, S. McLornan, D. Narayanan, S. Sullivan, J. O.
McMullin, M. F.
Ghebretinsea, F.
Boucher, R.
Francis, S.
Horne, G.
Hussein, H.
Knapper, S.
McLornan, D.
Narayanan, S.
Sullivan, J. O.
Abstract
Description
Date
2025
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 172.34 KB
Keywords
Type
Article
Citation
McMullin MF, Ghebretinsea F, Boucher R, Francis S, Horne G, Hussein H, et al. Fedora preliminary analysis of a Phase II study evaluating the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis. Blood. 2025 NOV 3;146:486-7.